Contra-indications for administering bronchodilator drugs
The number of contra-indications to administering short-acting ß2-sympathomimetics by inhalation is limited. Prudence is called for in patients with
- heart failure
- decreased glucose tolerance
- manifest diabetes mellitus
- concomitant use of heart glycosides.
However, the risk of a single administration,
for diagnostic purposes, is minimal.
Apart from ‘hypersensitivity’ to atropine-like substances, anticholinergics administered by inhalation have no contra-indications.